Health Aug 11 Insurers view new Alzheimer’s drug as experimental, won’t cover treatment for some customers By Tom Murphy, Associated Press
Health Jul 06 Alzheimer’s drug Leqembi has full FDA approval, clearing way for Medicare coverage The FDA gave it conditional approval in January based on early results suggesting the drug could modestly slow cognitive decline. By Matthew Perrone, Associated Press